Rhythm shares close higher after AstraZeneca reportedly offered $10 billion takeover

RYTM•2026-11-04

Rhythm Pharmaceuticals shares closed 28% higher at $110.68 after AstraZeneca reportedly made a roughly $10 billion takeover offer last month at $124 per share.

1. Reported takeover offer

Rhythm Pharmaceuticals shares closed up 28% at $110.68 after a report said AstraZeneca made a roughly $10 billion takeover offer for the company last month, offering $124 per share. The report cited people familiar with the matter. AstraZeneca declined to comment, while Rhythm did not respond to a request for comment. Rhythm shares traded at $108.44 in extended trading.

Sources

AstraZeneca made $10 billion offer for Rhythm Pharmaceuticals

Tinyurl

Rhythm shares close higher after AstraZeneca reportedly offered $10 billion takeover

1. Reported takeover offer

Related News

Valuence Merger Corp. I board extends business combination deadline to Dec. 3, 2026

Annovis Bio launches proposed public offering of common stock and warrants

Traeger Q3 FY26 net loss narrows 68% to $28.5 million; revenue drops 40% to $74.7 million

Sources

AstraZeneca made $10 billion offer for Rhythm Pharmaceuticals

CVS to break up $117 billion business, separating pharmacies from insurance; shares fall

Reynolds Consumer Products publishes Q3 2026 earnings call transcript